Curis Lifesciences IPO Peer Comparison
Curis Lifesciences Ltd. peer comparison with similar listed entities. (As on March 31, 2025)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|
| Curis Lifesciences Limited | 10.29 | 10.29 | 27.34 | | 37.62 | | Restated |
| Sotac Pharmaceuticals Limited | 4.32 | 4.32 | 47.99 | 18.30 | 9.00 | 2.72 | |
| Lincoln Pharmaceuticals Limited | 41.11 | 41.11 | 335.34 | 12.21 | 12.27 | 1.58 | |
Notes:
- Source - All the financial information for listed industry peers mentioned above is sourced from the published results of the aforesaid companies for the year ended March 31, 2025 and stock exchange data dated 31/03/2025 to compute the corresponding financial ratios. For our Company, current market price and PE ratio of our company will be determined at the end of book building process. For peer companies, P/E Ratio is based on the market price as on October 28, 2025 and October 28, 2025 for Sotac Pharmaceuticals Limited and Lincoln Pharmaceuticals Limited, respectively.
- The EPS, NAV, RoNW and total Income of our Company are taken as per Restated Financial Statement for the Financial Year 2024-25.
